Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner

Lianjun Zhang1, Benjamin O Tschumi1, Isabel C Lopez-Mejia2

  • 1Ludwig Center for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland.

Cell Reports
|January 26, 2016
PubMed

Insights

Mammalian target of rapamycin complex 2 (mTORC2) regulates CD8 T cell differentiation. Its deficiency enhances memory formation and recall responses, offering potential immunotherapy targets.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • CD8 T cell activation upon infection leads to short-lived effector cells (SLECs) and memory precursor cells (MPECs).
  • The signaling pathways governing this differentiation are not fully understood.
  • Mammalian target of rapamycin complex 2 (mTORC2) is a key signaling complex.

Purpose of the Study:

  • To investigate the role of Rictor, a core component of mTORC2, in CD8 T cell differentiation.
  • To elucidate the molecular mechanisms by which mTORC2 influences T cell fate.

Main Methods:

  • Utilized Rictor knockout (KO) models.
  • Analyzed CD8 T cell differentiation, effector functions, and memory formation.
  • Assessed gene expression (Eomes, Tcf-1, T-bet), mitochondrial respiration, fatty acid oxidation, and Foxo1 activity.

Main Results:

  • Rictor deficiency promoted memory precursor cell (MPEC) commitment over short-lived effector cell (SLEC) differentiation.
  • mTORC2-deficient CD8 T cells showed enhanced IL-2 secretion, potent recall responses, and improved effector functions.
  • Key findings included Eomes/Tcf-1 upregulation, T-bet repression, enhanced mitochondrial function, and Foxo1 nuclear stabilization.

Conclusions:

  • mTORC2 is a critical regulator of CD8 T cell differentiation, favoring effector cell fate.
  • Rictor deficiency enhances memory formation and recall responses through Foxo1-mediated transcriptional and metabolic reprogramming.
  • mTORC2 inhibition represents a potential therapeutic strategy for enhancing T cell-based immunotherapies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
10.0K